Exchange Traded Concepts LLC Makes New $304,000 Investment in Utah Medical Products, Inc. (NASDAQ:UTMD)

Exchange Traded Concepts LLC bought a new stake in Utah Medical Products, Inc. (NASDAQ:UTMD) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,549 shares of the medical instruments supplier’s stock, valued at approximately $304,000. Exchange Traded Concepts LLC owned 0.13% of Utah Medical Products at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Quadrature Capital Ltd increased its stake in Utah Medical Products by 177.6% in the first quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock worth $2,294,000 after purchasing an additional 20,671 shares during the period. Vanguard Group Inc. lifted its holdings in Utah Medical Products by 7.3% during the 1st quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after buying an additional 12,402 shares in the last quarter. Los Angeles Capital Management LLC lifted its holdings in Utah Medical Products by 127.0% during the 1st quarter. Los Angeles Capital Management LLC now owns 13,086 shares of the medical instruments supplier’s stock valued at $931,000 after buying an additional 7,320 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in Utah Medical Products by 4.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock valued at $1,632,000 after buying an additional 947 shares during the period. Finally, Brandes Investment Partners LP grew its stake in Utah Medical Products by 66.2% in the 2nd quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock worth $7,789,000 after acquiring an additional 46,427 shares in the last quarter. 69.60% of the stock is owned by institutional investors.

Utah Medical Products Stock Performance

Shares of NASDAQ:UTMD opened at $66.30 on Monday. The firm has a market cap of $230.72 million, a PE ratio of 15.31 and a beta of 0.08. The firm’s 50 day simple moving average is $66.78 and its 200-day simple moving average is $67.70. Utah Medical Products, Inc. has a one year low of $64.90 and a one year high of $87.86.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings data on Thursday, July 25th. The medical instruments supplier reported $0.98 EPS for the quarter. Utah Medical Products had a return on equity of 12.41% and a net margin of 33.56%. The company had revenue of $10.40 million for the quarter.

Utah Medical Products Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 4th. Investors of record on Friday, September 20th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.81%. The ex-dividend date was Friday, September 20th. Utah Medical Products’s dividend payout ratio (DPR) is presently 27.71%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.